April 8, 2021
SEC Announces Dr. James Crowe Wins 2021 Faculty Achievement Award for Vanderbilt University
By: SEC Staff
SECU (Twitter: @TheSECU)
BIRMINGHAM, Ala. (April 8, 2021) – Dr. James Crowe, Professor of Pediatrics and Pathology, Microbiology and Immunology in the School of Medicine, has been named winner of the 2021 SEC Faculty Achievement Award for Vanderbilt University, the SEC announced on Thursday.
A board certified pediatric infectious diseases physician and viral immunology researcher, Dr. Crowe is a member of the National Academy of Medicine and the National Academy of Inventors. He is a named inventor on approximately 100 patents and patent families for vaccines and antibodies. His research interests are in the human immune response to infection, and his work has been supported by the National Institutes of Health, agencies within the U.S. Department of Defense and numerous foundations. He has been published in journals such as Nature, New England Journal of Medicine and Journal of the American Medical Association.
“Pandemic prevention, one of the most crucial scientific endeavors of our time, owes its current promise to decades of pioneering work by Dr. James Crowe, one of the world’s leading experts on the molecular basis for human immunity to viruses, including COVID-19,” said Dr. Susan Wente, Provost and Vice Chancellor at Vanderbilt University. “His work embodies the pinnacle of higher education’s mission to improve the human condition, and no other immunologist working today has had such broad and lasting social impact.”
To receive an SEC achievement award, the faculty member must have achieved the rank of full professor; have a record of extraordinary teaching, particularly at the undergraduate level; and have a record of research that is recognized nationally and/or internationally. University winners will receive a $5,000 honorarium from the SEC and will become their campus nominee for the SEC Professor of the Year Award, which will be announced in April.
Click here to learn more about Dr. James Crowe.